id	sid	eid	entity	type
dti-1331	1	1	moretti	PERSON
dti-1331	1	2	2008:3	CARDINAL
dti-1331	1	3	rita moretti	PERSON
dti-1331	1	4	m.d.	GPE
dti-1331	1	5	university of trieste	ORG
dti-1331	1	6	34149	CARDINAL
dti-1331	1	7	italy	GPE
dti-1331	2	1	+39-40-910861	CARDINAL
dti-1331	4	1	rita moretti	PERSON
dti-1331	4	2	paola torre	PERSON
dti-1331	4	3	cristina vilotti	PERSON
dti-1331	4	4	davide manganaro	PERSON
dti-1331	4	5	rodolfo m. antonello	PERSON
dti-1331	4	6	university of trieste	ORG
dti-1331	4	7	italy	GPE
dti-1331	5	1	nmda	ORG
dti-1331	10	1	nmda	ORG
dti-1331	10	2	about one-third	CARDINAL
dti-1331	11	1	rothman et al	PERSON
dti-1331	11	2	1987	DATE
dti-1331	12	1	1995	DATE
dti-1331	13	1	2000	DATE
dti-1331	14	1	three	CARDINAL
dti-1331	14	2	methyl4	PERSON
dti-1331	14	3	n-methyl-d-aspartate	PRODUCT
dti-1331	14	4	nmda	ORG
dti-1331	15	1	2000	DATE
dti-1331	16	1	four	CARDINAL
dti-1331	16	2	glur1	ORG
dti-1331	17	1	ca2+	GPE
dti-1331	18	1	nmda	ORG
dti-1331	18	2	ca2+	ORG
dti-1331	18	3	2000	DATE
dti-1331	19	1	the nmda channel	ORG
dti-1331	20	1	nmda	ORG
dti-1331	20	2	mg2+	GPE
dti-1331	22	1	mg2+	GPE
dti-1331	22	2	nmda	ORG
dti-1331	22	3	the nmda channel	ORG
dti-1331	22	4	2000	DATE
dti-1331	24	1	nmda	ORG
dti-1331	24	2	ltp	GPE
dti-1331	24	3	ca1	ORG
dti-1331	24	4	1995	DATE
dti-1331	24	5	parsons et al	PERSON
dti-1331	24	6	1998	DATE
dti-1331	24	7	fischer et al	PERSON
dti-1331	24	8	1977	DATE
dti-1331	26	1	http://creativecommons.org/licenses/by/3.0/.	DATE
dti-1331	26	2	moretti	PERSON
dti-1331	26	3	2008:3	CARDINAL
dti-1331	31	1	nmda	ORG
dti-1331	31	2	chen et al	PERSON
dti-1331	31	3	1997	DATE
dti-1331	31	4	1997	DATE
dti-1331	31	5	borman et al	PERSON
dti-1331	31	6	1989	DATE
dti-1331	32	1	100 micromol	QUANTITY
dti-1331	32	2	1989	DATE
dti-1331	33	1	nmda	ORG
dti-1331	33	2	1988	DATE
dti-1331	33	3	chen et al	PERSON
dti-1331	33	4	1999	DATE
dti-1331	33	5	1999	DATE
dti-1331	34	1	approximately one-sixth	CARDINAL
dti-1331	34	2	1999	DATE
dti-1331	35	1	1993	DATE
dti-1331	35	2	krieglstein et al. 1996	PERSON
dti-1331	35	3	1991	DATE
dti-1331	35	4	weller et al	ORG
dti-1331	35	5	1993	DATE
dti-1331	35	6	pellegrini et al	PERSON
dti-1331	35	7	1993	DATE
dti-1331	37	1	nmda	ORG
dti-1331	37	2	wenk et al	PERSON
dti-1331	37	3	1997	DATE
dti-1331	38	1	rao et al. 2001	PERSON
dti-1331	38	2	gorgiilii et al	PERSON
dti-1331	38	3	2000	DATE
dti-1331	39	1	dogan et al	PERSON
dti-1331	39	2	1999	DATE
dti-1331	39	3	seif ej	PERSON
dti-1331	39	4	1990	DATE
dti-1331	39	5	heim et al. 1995)	ORG
dti-1331	39	6	1999	DATE
dti-1331	39	7	1992	DATE
dti-1331	40	1	5–50 mg/kg	QUANTITY
dti-1331	40	2	1992	DATE
dti-1331	41	1	2002	DATE
dti-1331	42	1	2003	DATE
dti-1331	42	2	fda	ORG
dti-1331	43	1	the european commission	ORG
dti-1331	43	2	october 2005	DATE
dti-1331	45	1	neurofi brillary	ORG
dti-1331	45	2	1993	DATE
dti-1331	45	3	francis et al	PERSON
dti-1331	45	4	1993	DATE
dti-1331	47	1	li et al.	PERSON
dti-1331	47	2	1997	DATE
dti-1331	48	1	nmda receptors	ORG
dti-1331	48	2	giulian et al	PERSON
dti-1331	48	3	1995	DATE
dti-1331	48	4	1997	DATE
dti-1331	49	1	nmda	ORG
dti-1331	49	2	goodwin et al.	PERSON
dti-1331	49	3	1995	DATE
dti-1331	49	4	1–40	CARDINAL
dti-1331	49	5	goodwin et al.	PERSON
dti-1331	50	1	1995	DATE
dti-1331	51	1	mattson et al	ORG
dti-1331	51	2	1992	DATE
dti-1331	51	3	wu et al.	PERSON
dti-1331	51	4	1995	DATE
dti-1331	51	5	nmda	ORG
dti-1331	51	6	cullen et al	PERSON
dti-1331	51	7	1996	DATE
dti-1331	53	1	nmda	ORG
dti-1331	53	2	-carboxypiperazin4-yl)propyl-1-phosphonic	PERSON
dti-1331	53	3	cullen et al	PERSON
dti-1331	53	4	1996	DATE
dti-1331	54	1	79	CARDINAL
dti-1331	54	2	2008:3	CARDINAL
dti-1331	55	1	nmda	ORG
dti-1331	56	1	252	CARDINAL
dti-1331	56	2	126	CARDINAL
dti-1331	56	3	20 mg	QUANTITY
dti-1331	56	4	28 weeks	DATE
dti-1331	57	1	nyu	ORG
dti-1331	57	2	daily	DATE
dti-1331	57	3	2003	DATE
dti-1331	57	4	reisberg et al.	PERSON
dti-1331	57	5	2000	DATE
dti-1331	58	1	two	CARDINAL
dti-1331	58	2	166	CARDINAL
dti-1331	58	3	10 mg	QUANTITY
dti-1331	58	4	12 weeks	DATE
dti-1331	60	1	daily	DATE
dti-1331	61	1	three	CARDINAL
dti-1331	62	1	aes	ORG
dti-1331	62	2	aes	ORG
dti-1331	62	3	winblad et al	PERSON
dti-1331	62	4	1999	DATE
dti-1331	64	1	20 mg	QUANTITY
dti-1331	64	2	daily	DATE
dti-1331	64	3	28 weeks	DATE
dti-1331	64	4	2003	DATE
dti-1331	65	1	252	CARDINAL
dti-1331	66	1	181	CARDINAL
dti-1331	66	2	72%	PERCENT
dti-1331	66	3	week 28	DATE
dti-1331	67	1	71	CARDINAL
dti-1331	67	2	42	CARDINAL
dti-1331	67	3	29	CARDINAL
dti-1331	68	1	0.06	CARDINAL
dti-1331	68	2	0.03	CARDINAL
dti-1331	68	3	daily	DATE
dti-1331	68	4	0.02	CARDINAL
dti-1331	68	5	0.003	CARDINAL
dti-1331	68	6	0.001	CARDINAL
dti-1331	68	7	0.002	CARDINAL
dti-1331	70	1	bleich et al	PERSON
dti-1331	70	2	2003	DATE
dti-1331	72	1	24-week	DATE
dti-1331	72	2	37	CARDINAL
dti-1331	72	3	hartmann et al	FAC
dti-1331	72	4	2003	DATE
dti-1331	73	1	mmse (	ORG
dti-1331	73	2	6-month	DATE
dti-1331	73	3	achei	PRODUCT
dti-1331	73	4	the past 3 months	DATE
dti-1331	74	1	daily	DATE
dti-1331	75	1	24	CARDINAL
dti-1331	77	1	germany	GPE
dti-1331	77	2	84%	PERCENT
dti-1331	77	3	15%	PERCENT
dti-1331	77	4	200	CARDINAL
dti-1331	78	1	achei	NORP
dti-1331	78	2	achei	NORP
dti-1331	78	3	2003	DATE
dti-1331	78	4	2004	DATE
dti-1331	78	5	knopman	PERSON
dti-1331	78	6	2005	DATE
dti-1331	78	7	2004	DATE
dti-1331	78	8	sudhir	ORG
dti-1331	78	9	2004	DATE
dti-1331	79	1	schmitt et al.	PERSON
dti-1331	79	2	2006	DATE
dti-1331	79	3	24 week	DATE
dti-1331	80	1	benefi	PERSON
dti-1331	81	1	schmitt et al. 2006	ORG
dti-1331	82	1	jones et al	PERSON
dti-1331	82	2	2007	DATE
dti-1331	82	3	confi	PERSON
dti-1331	82	4	80	CARDINAL
dti-1331	82	5	moretti	PERSON
dti-1331	82	6	2008:3	CARDINAL
dti-1331	82	7	winblad et al.	PERSON
dti-1331	82	8	2006	DATE
dti-1331	83	1	jones et al	PERSON
dti-1331	83	2	2007	DATE
dti-1331	86	1	fl	ORG
dti-1331	90	1	nmda	ORG
dti-1331	91	1	second	ORDINAL
dti-1331	94	1	second	ORDINAL
dti-1331	96	1	1–3 days	DATE
dti-1331	98	1	three days	DATE
dti-1331	98	2	7–28 days	DATE
dti-1331	100	1	nmda	ORG
dti-1331	100	2	mortimer et al	PERSON
dti-1331	100	3	1991	DATE
dti-1331	100	4	orgogozo et al	PERSON
dti-1331	100	5	2002	DATE
dti-1331	101	1	physiological nmda	ORG
dti-1331	102	1	huntington	GPE
dti-1331	103	1	lipton	ORG
dti-1331	103	2	2004	DATE
dti-1331	103	3	2002	DATE
dti-1331	105	1	28-week	DATE
dti-1331	105	2	france	GPE
dti-1331	105	3	321	CARDINAL
dti-1331	105	4	10 mg	QUANTITY
dti-1331	105	5	288	CARDINAL
dti-1331	106	1	between 12 and 20	CARDINAL
dti-1331	107	1	2	CARDINAL
dti-1331	107	2	adas-cog	ORG
dti-1331	107	3	2002	DATE
dti-1331	108	1	28 weeks	DATE
dti-1331	108	2	adas-cog	PERSON
dti-1331	109	1	0.4	CARDINAL
dti-1331	109	2	1.6	CARDINAL
dti-1331	109	3	95%	PERCENT
dti-1331	109	4	0.49	CARDINAL
dti-1331	109	5	3.60	CARDINAL
dti-1331	110	1	60%	PERCENT
dti-1331	110	2	52%	PERCENT
dti-1331	110	3	0.227	CARDINAL
dti-1331	111	1	mmse	NORP
dti-1331	111	2	0.003	CARDINAL
dti-1331	111	3	2002	DATE
dti-1331	113	1	jarvis et al	PERSON
dti-1331	113	2	2002	DATE
dti-1331	114	1	81	CARDINAL
dti-1331	114	2	2008:3	CARDINAL
dti-1331	115	1	28-week	DATE
dti-1331	115	2	20	CARDINAL
dti-1331	115	3	daily	DATE
dti-1331	115	4	vad	PERSON
dti-1331	115	5	54	CARDINAL
dti-1331	115	6	u.k.	GPE
dti-1331	116	1	579	CARDINAL
dti-1331	116	2	548	CARDINAL
dti-1331	116	3	at least one	CARDINAL
dti-1331	117	1	vad	GPE
dti-1331	117	2	95%	PERCENT
dti-1331	117	3	−3.023	GPE
dti-1331	117	4	−0.49	GPE
dti-1331	117	5	2	CARDINAL
dti-1331	117	6	two	CARDINAL
dti-1331	118	1	demaerschalk	PERSON
dti-1331	118	2	2007	DATE
dti-1331	118	3	eight	CARDINAL
dti-1331	119	1	5 mg	QUANTITY
dti-1331	120	1	nnt	ORG
dti-1331	120	2	10	CARDINAL
dti-1331	120	3	50	CARDINAL
dti-1331	121	1	24 mg	QUANTITY
dti-1331	121	2	7	CARDINAL
dti-1331	122	1	insuffi cient	PERSON
dti-1331	126	1	1999	DATE
dti-1331	127	1	1-methyl-4	QUANTITY
dti-1331	127	2	2000	DATE
dti-1331	128	1	italian	NORP
dti-1331	128	2	2007	DATE
dti-1331	129	1	di luca	PERSON
dti-1331	129	2	2006	DATE
dti-1331	131	1	2003	DATE
dti-1331	131	2	phillips et al	PERSON
dti-1331	131	3	2003	DATE
dti-1331	133	1	2007	DATE
dti-1331	135	1	2001	DATE
dti-1331	135	2	1-methyl-4	QUANTITY
dti-1331	135	3	2003	DATE
dti-1331	136	1	liss	PERSON
dti-1331	136	2	2005	DATE
dti-1331	138	1	2004	DATE
dti-1331	138	2	liss	PERSON
dti-1331	138	3	2005	DATE
dti-1331	138	4	82	CARDINAL
dti-1331	138	5	moretti	PERSON
dti-1331	138	6	2008:3	CARDINAL
dti-1331	139	1	1999	DATE
dti-1331	139	2	2000	DATE
dti-1331	139	3	nmda	ORG
dti-1331	140	1	giustizieri et al	PERSON
dti-1331	140	2	2007	DATE
dti-1331	140	3	nmda	ORG
dti-1331	142	1	14	CARDINAL
dti-1331	142	2	1992	DATE
dti-1331	142	3	30 mg/day	QUANTITY
dti-1331	143	1	one month	DATE
dti-1331	143	2	10	CARDINAL
dti-1331	143	3	4	CARDINAL
dti-1331	144	1	5	CARDINAL
dti-1331	144	2	1	CARDINAL
dti-1331	145	1	6	CARDINAL
dti-1331	145	2	daily	DATE
dti-1331	145	3	273 minutes	TIME
dti-1331	145	4	172 minutes	TIME
dti-1331	147	1	1999	DATE
dti-1331	148	1	twelve	CARDINAL
dti-1331	148	2	nmda	ORG
dti-1331	150	1	the unifi ed parkinson’s	ORG
dti-1331	150	2	13.5	CARDINAL
dti-1331	150	3	0.003	CARDINAL
dti-1331	153	1	2007	DATE
dti-1331	155	1	917	CARDINAL
dti-1331	156	1	23	CARDINAL
dti-1331	156	2	137	CARDINAL
dti-1331	157	1	19	CARDINAL
dti-1331	158	1	n-methyl-d-aspartate	QUANTITY
dti-1331	158	2	3)h	CARDINAL
dti-1331	158	3	801	CARDINAL
dti-1331	159	1	400	CARDINAL
dti-1331	159	2	35)s]gtpgamma	CARDINAL
dti-1331	159	3	chinese	NORP
dti-1331	159	4	1200	CARDINAL
dti-1331	160	1	400	CARDINAL
dti-1331	161	1	between 200 and 2000	CARDINAL
dti-1331	162	1	nmda receptors	ORG
dti-1331	165	1	nmda	ORG
dti-1331	169	1	83	CARDINAL
dti-1331	169	2	2008:3	CARDINAL
dti-1331	169	3	6 months	DATE
dti-1331	171	1	2007	DATE
dti-1331	172	1	1	CARDINAL
dti-1331	173	1	two	CARDINAL
dti-1331	173	2	three six month	DATE
dti-1331	174	1	six months	DATE
dti-1331	174	2	2.97	CARDINAL
dti-1331	174	3	100	CARDINAL
dti-1331	174	4	95%	PERCENT
dti-1331	174	5	1.68	CARDINAL
dti-1331	174	6	4.26	CARDINAL
dti-1331	174	7	0.00001	CARDINAL
dti-1331	174	8	daily	DATE
dti-1331	174	9	1.27	CARDINAL
dti-1331	174	10	54	CARDINAL
dti-1331	174	11	95%	PERCENT
dti-1331	174	12	0.44	CARDINAL
dti-1331	174	13	2.09	CARDINAL
dti-1331	174	14	0.003	CARDINAL
dti-1331	174	15	2.76	CARDINAL
dti-1331	174	16	144	CARDINAL
dti-1331	174	17	npi	ORG
dti-1331	174	18	95%	PERCENT
dti-1331	174	19	0.88	CARDINAL
dti-1331	174	20	4.63	CARDINAL
dti-1331	174	21	0.004	CARDINAL
dti-1331	174	22	0.28	CARDINAL
dti-1331	174	23	7	CARDINAL
dti-1331	174	24	95%	PERCENT
dti-1331	174	25	0.15	CARDINAL
dti-1331	174	26	0.41	CARDINAL
dti-1331	174	27	0.0001	CARDINAL
dti-1331	175	1	2.	CARDINAL
dti-1331	176	1	three	CARDINAL
dti-1331	176	2	six months	DATE
dti-1331	176	3	0.99	CARDINAL
dti-1331	176	4	70	CARDINAL
dti-1331	176	5	adas-cog	PERSON
dti-1331	176	6	95%	PERCENT
dti-1331	176	7	ci 0.21 to	PERSON
dti-1331	176	8	1.78	CARDINAL
dti-1331	176	9	0.01	CARDINAL
dti-1331	176	10	0.13	CARDINAL
dti-1331	176	11	95%	PERCENT
dti-1331	176	12	0.01	CARDINAL
dti-1331	176	13	0.25	CARDINAL
dti-1331	176	14	0.03	CARDINAL
dti-1331	176	15	daily	DATE
dti-1331	177	1	3	CARDINAL
dti-1331	178	1	two six month	DATE
dti-1331	178	2	1.85	CARDINAL
dti-1331	178	3	adas-cog	ORG
dti-1331	178	4	95%	PERCENT
dti-1331	178	5	0.88	CARDINAL
dti-1331	178	6	2.83	CARDINAL
dti-1331	178	7	0.0002	CARDINAL
dti-1331	178	8	0.84 95%	PERCENT
dti-1331	178	9	0.06	CARDINAL
dti-1331	178	10	0.91	CARDINAL
dti-1331	178	11	0.03	CARDINAL
dti-1331	179	1	4	CARDINAL
dti-1331	179	2	134/1739	CARDINAL
dti-1331	179	3	7.7%	PERCENT
dti-1331	179	4	175/1873	CARDINAL
dti-1331	179	5	9.3%	PERCENT
dti-1331	179	6	0.78	CARDINAL
dti-1331	179	7	95%	PERCENT
dti-1331	179	8	0.61	CARDINAL
dti-1331	179	9	0.99	CARDINAL
dti-1331	179	10	0.04	CARDINAL
dti-1331	180	1	12%	PERCENT
dti-1331	181	1	18%	PERCENT
dti-1331	181	2	0.6,	PERCENT
dti-1331	181	3	95%	PERCENT
dti-1331	181	4	0.42	CARDINAL
dti-1331	181	5	0.86	CARDINAL
dti-1331	181	6	0.005	CARDINAL
dti-1331	186	1	mara conte	PERSON
dti-1331	187	1	danieczyk	GPE
dti-1331	187	2	w. 1988	PERSON
dti-1331	189	1	21(3):144–6	CARDINAL
dti-1331	190	1	t.a.	GPE
dti-1331	190	2	f.a.	GPE
dti-1331	190	3	aizenman	PERSON
dti-1331	190	4	e. et al.	PERSON
dti-1331	190	5	1997	DATE
dti-1331	190	6	jan.	GPE
dti-1331	192	1	j. neurophysiol	PERSON
dti-1331	193	1	77(i):309–23	CARDINAL
dti-1331	193	2	bleich, s.	PERSON
dti-1331	193	3	wiltfang	GPE
dti-1331	193	4	j., kornhuber	ORG
dti-1331	193	5	j., reisberg	ORG
dti-1331	193	6	b.	PERSON
dti-1331	193	7	r.	NORP
dti-1331	193	8	2003	DATE
dti-1331	196	1	j. med.	PERSON
dti-1331	196	2	349:609–10	DATE
dti-1331	197	1	j. 1989, aug 3	ORG
dti-1331	197	2	n.-methyldaspartate	ORG
dti-1331	197	3	nmda	ORG
dti-1331	199	1	j. pharmacol.	ORG
dti-1331	199	2	166(3):591–2	CARDINAL
dti-1331	200	1	braak	ORG
dti-1331	200	2	h.	PERSON
dti-1331	200	3	braak	GPE
dti-1331	200	4	e.	PERSON
dti-1331	200	5	bohl	PERSON
dti-1331	200	6	j. 1993	ORG
dti-1331	203	1	neurol	GPE
dti-1331	203	2	33:403–8	CARDINAL
dti-1331	204	1	brorson	PERSON
dti-1331	204	2	j.r.	GPE
dti-1331	204	3	bindokas	GPE
dti-1331	204	4	y.p.	GPE
dti-1331	204	5	iwama	GPE
dti-1331	204	6	i.	GPE
dti-1331	204	7	marcuccilli	PERSON
dti-1331	204	8	c.j.	GPE
dti-1331	204	9	chisholm	GPE
dti-1331	204	10	j.c.	PERSON
dti-1331	204	11	miller	ORG
dti-1331	204	12	r.j. 1995	PERSON
dti-1331	206	1	j. neurobiol	PERSON
dti-1331	206	2	26:325–38	CARDINAL
dti-1331	207	1	chapira	GPE
dti-1331	207	2	a.h. 2001	GPE
dti-1331	210	1	neurol	GPE
dti-1331	211	1	86:155–62	DATE
dti-1331	212	1	chen	PERSON
dti-1331	212	2	lipton, s.a. 1997,	ORG
dti-1331	212	3	feb 15	DATE
dti-1331	213	1	j. physiol	PERSON
dti-1331	214	1	499(pt	CARDINAL
dti-1331	215	1	d.w. 1995	ORG
dti-1331	217	1	18:58–60	DATE
dti-1331	218	1	cullen	PERSON
dti-1331	218	2	w.k.	GPE
dti-1331	218	3	wu	PERSON
dti-1331	218	4	j.q.	GPE
dti-1331	218	5	anwyl	GPE
dti-1331	218	6	r.	NORP
dti-1331	218	7	rowan	PERSON
dti-1331	218	8	m.j. 1996	PERSON
dti-1331	220	1	neuroreport	GPE
dti-1331	221	1	w., zajaczkowski	PERSON
dti-1331	221	2	w.	PERSON
dti-1331	221	3	c.g. 1995	PERSON
dti-1331	223	1	behav	PERSON
dti-1331	225	1	6:455–74	CARDINAL
dti-1331	225	2	w.	PERSON
dti-1331	225	3	c.g.	GPE
dti-1331	225	4	mobius	PERSON
dti-1331	225	5	h.j.	GPE
dti-1331	225	6	a.	PERSON
dti-1331	225	7	2000	DATE
dti-1331	226	1	unifi ed glutamatergic hypothesis	ORG
dti-1331	228	1	2:85–97	TIME
dti-1331	229	1	demaerschalk	PERSON
dti-1331	229	2	b.m.	GPE
dti-1331	229	3	2007	DATE
dti-1331	229	4	jan.	GPE
dti-1331	231	1	dogan, a.	ORG
dti-1331	231	2	m.a.	GPE
dti-1331	231	3	rao	ORG
dti-1331	232	1	1999	DATE
dti-1331	235	1	141(10):1107–13	CARDINAL
dti-1331	235	2	erdo	ORG
dti-1331	235	3	s.l.	ORG
dti-1331	235	4	schafer	ORG
dti-1331	235	5	m. 1991	PERSON
dti-1331	237	1	j. pharmacol.	ORG
dti-1331	237	2	198(2–3):215–7	CARDINAL
dti-1331	238	1	fischer	ORG
dti-1331	238	2	p-a.	ORG
dti-1331	238	3	jacobi	PERSON
dti-1331	238	4	schneider	PERSON
dti-1331	238	5	e. et al	PERSON
dti-1331	238	6	1977	DATE
dti-1331	240	1	27(ii)(7):1487–9	CARDINAL
dti-1331	241	1	floresco	ORG
dti-1331	241	2	s.b.	GPE
dti-1331	241	3	west,	GPE
dti-1331	241	4	a.r.	GPE
dti-1331	241	5	moore	PERSON
dti-1331	241	6	h.	PERSON
dti-1331	241	7	a.a. 2003	GPE
dti-1331	243	1	nat	DATE
dti-1331	244	1	neurosci	PERSON
dti-1331	245	1	6:968–73	CARDINAL
dti-1331	245	2	84	CARDINAL
dti-1331	245	3	moretti	PERSON
dti-1331	245	4	2008:3	CARDINAL
dti-1331	245	5	p.i.	GPE
dti-1331	245	6	n.r.	GPE
dti-1331	245	7	procter	PERSON
dti-1331	245	8	a.w.	GPE
dti-1331	245	9	bowen	PERSON
dti-1331	245	10	1993	DATE
dti-1331	247	1	j. neurochem	PERSON
dti-1331	248	1	60:1589–604	DATE
dti-1331	248	2	c.g. 1999	PERSON
dti-1331	248	3	sep	PRODUCT
dti-1331	248	4	nmda	ORG
dti-1331	248	5	mg2+	LOC
dti-1331	249	1	38(9):1253–9	DATE
dti-1331	250	1	f.	PERSON
dti-1331	250	2	di luca	PERSON
dti-1331	250	3	m. 2006	PERSON
dti-1331	253	1	j. pharmacol.	ORG
dti-1331	253	2	545:2–10	CARDINAL
dti-1331	253	3	giulian	PERSON
dti-1331	253	4	d.	NORP
dti-1331	253	5	l.j.	GPE
dti-1331	253	6	li	PERSON
dti-1331	253	7	l.	GPE
dti-1331	253	8	w.l.	GPE
dti-1331	253	9	yu, l.	PERSON
dti-1331	253	10	tom	PERSON
dti-1331	253	11	d.	NORP
dti-1331	253	12	li	PERSON
dti-1331	253	13	x.	GPE
dti-1331	253	14	kirkpatrick	ORG
dti-1331	253	15	j.b. 1995	GPE
dti-1331	257	1	27:119–37	DATE
dti-1331	258	1	giustizieri	PERSON
dti-1331	258	2	m.	PERSON
dti-1331	258	3	m.l.	GPE
dti-1331	258	4	guatteo	PERSON
dti-1331	258	5	mercuri	GPE
dti-1331	258	6	n.b.	GPE
dti-1331	258	7	2007	DATE
dti-1331	258	8	may 11	DATE
dti-1331	259	1	atp-dependent	PERSON
dti-1331	259	2	compacta jpet	ORG
dti-1331	261	1	goodwin	PERSON
dti-1331	261	2	j.l.	GPE
dti-1331	261	3	demura	ORG
dti-1331	261	4	cunnick	PERSON
dti-1331	261	5	1995	DATE
dti-1331	263	1	692:207–14	CARDINAL
dti-1331	263	2	gorgiilii, a.	PERSON
dti-1331	263	3	kins	PERSON
dti-1331	263	4	t.	GPE
dti-1331	263	5	s. et al	PERSON
dti-1331	263	6	2000	DATE
dti-1331	264	1	acta	PERSON
dti-1331	265	1	142(11):1287–92	CARDINAL
dti-1331	266	1	hartmann	GPE
dti-1331	266	2	s.	PERSON
dti-1331	266	3	mobius	PERSON
dti-1331	266	4	h. 2003	PERSON
dti-1331	269	1	clin	PERSON
dti-1331	270	1	psychopharmacol	PERSON
dti-1331	271	1	heim	ORG
dti-1331	271	2	c.	PERSON
dti-1331	271	3	sontag	GPE
dti-1331	271	4	k.h. 1995	GPE
dti-1331	273	1	j. neura.l transm	PERSON
dti-1331	273	2	46(supp1):17–30	DATE
dti-1331	274	1	jarvis	PERSON
dti-1331	274	2	b.	PERSON
dti-1331	274	3	figgitt	GPE
dti-1331	274	4	d.p. 2003	GPE
dti-1331	276	1	20(6):465–76	DATE
dti-1331	277	1	jones	ORG
dti-1331	277	2	r.w.	GPE
dti-1331	277	3	bayer, a.	ORG
dti-1331	277	4	inglis	PERSON
dti-1331	277	5	f. et al	PERSON
dti-1331	277	6	2007	DATE
dti-1331	277	7	january	DATE
dti-1331	280	1	j. geriatr	PERSON
dti-1331	282	1	keilhoff	ORG
dti-1331	282	2	wolf	PERSON
dti-1331	282	3	1992	DATE
dti-1331	282	4	sep 4	DATE
dti-1331	284	1	j. pharmacol .	ORG
dti-1331	285	1	219(3):451–4	CARDINAL
dti-1331	286	1	a.	PERSON
dti-1331	286	2	mcgeer, p.l. 1997	ORG
dti-1331	288	1	j. neurosci	PERSON
dti-1331	289	1	49:229–35	CARDINAL
dti-1331	290	1	knopman	ORG
dti-1331	290	2	d. 2005	GPE
dti-1331	291	1	san francisco	GPE
dti-1331	293	1	american academy of neurology	ORG
dti-1331	293	2	krieglstein	PERSON
dti-1331	293	3	j.	PERSON
dti-1331	293	4	k.	PERSON
dti-1331	293	5	poch	PERSON
dti-1331	293	6	1996	DATE
dti-1331	295	1	35(no	DATE
dti-1331	296	1	j2):1737–42	PERSON
dti-1331	296	2	kucheryanu	PERSON
dti-1331	296	3	v.g.	GPE
dti-1331	296	4	kryzhanovskii	GPE
dti-1331	296	5	g.n. 2000	PERSON
dti-1331	298	1	bull exp	PERSON
dti-1331	300	1	130:629–32	DATE
dti-1331	301	1	li	PERSON
dti-1331	301	2	m.	PERSON
dti-1331	301	3	m., tanaka	PERSON
dti-1331	301	4	s.	PERSON
dti-1331	301	5	masliah	GPE
dti-1331	303	1	j. neuropathal	PERSON
dti-1331	305	1	neurol	GPE
dti-1331	307	1	56:901–11	CARDINAL
dti-1331	308	1	liss	PERSON
dti-1331	308	2	b.	PERSON
dti-1331	308	3	j., miki	PERSON
dti-1331	308	4	t.	GPE
dti-1331	308	5	seino	GPE
dti-1331	308	6	s.	PERSON
dti-1331	308	7	j. 2005	GPE
dti-1331	309	1	k-atp	PERSON
dti-1331	310	1	nat	PERSON
dti-1331	311	1	neurosci	PERSON
dti-1331	311	2	8:1742–51	DATE
dti-1331	311	3	lundbeck als	PERSON
dti-1331	311	4	h. 2002	ORG
dti-1331	314	1	h. lundbeck ais	PERSON
dti-1331	314	2	denmark l–13	ORG
dti-1331	315	1	mattson	ORG
dti-1331	315	2	m.p.	GPE
dti-1331	315	3	cheng	PERSON
dti-1331	315	4	b.	PERSON
dti-1331	315	5	davis	PERSON
dti-1331	315	6	d.	NORP
dti-1331	315	7	bryant	GPE
dti-1331	315	8	k.	PERSON
dti-1331	315	9	lieberburg	PERSON
dti-1331	315	10	1	CARDINAL
dti-1331	315	11	r.e.	PERSON
dti-1331	315	12	1992	DATE
dti-1331	317	1	j. neurosci	PERSON
dti-1331	317	2	12:376–89	DATE
dti-1331	318	1	mcshane	ORG
dti-1331	318	2	r.	NORP
dti-1331	318	3	areosa sastre,	ORG
dti-1331	318	4	a. and minakaran	PERSON
dti-1331	318	5	n. memantine	PERSON
dti-1331	318	6	2007	DATE
dti-1331	318	7	1	CARDINAL
dti-1331	319	1	merello	ORG
dti-1331	319	2	nouzeilles	PERSON
dti-1331	319	3	m.i.	GPE
dti-1331	319	4	leiguarda	GPE
dti-1331	320	1	nmda	ORG
dti-1331	321	1	clin	ORG
dti-1331	322	1	neuropharmacol	PERSON
dti-1331	323	1	22:273–6	CARDINAL
dti-1331	324	1	mortimer	PERSON
dti-1331	324	2	j.a.	GPE
dti-1331	324	3	c.m.	GPE
dti-1331	324	4	chandra	PERSON
dti-1331	324	5	a.b.	GPE
dti-1331	324	6	a.e.	GPE
dti-1331	324	7	kondo	PERSON
dti-1331	324	8	k.	PERSON
dti-1331	324	9	rocca	GPE
dti-1331	324	10	w.a.	GPE
dti-1331	324	11	shalat	GPE
dti-1331	324	12	s.l.	GPE
dti-1331	324	13	s.l.	GPE
dti-1331	324	14	a. 1991	PERSON
dti-1331	327	1	j. epidemiol.	PERSON
dti-1331	327	2	20(suppl 2):s28	DATE
dti-1331	327	3	j.m.	GPE
dti-1331	327	4	a.s.	GPE
dti-1331	327	5	mobius	PERSON
dti-1331	327	6	h.j.	GPE
dti-1331	329	1	33:1834–9	CARDINAL
dti-1331	330	1	parsons	ORG
dti-1331	330	2	c.g.	GPE
dti-1331	330	3	gruner	PERSON
dti-1331	330	4	r.	NORP
dti-1331	330	5	j. et al	PERSON
dti-1331	330	6	1993	DATE
dti-1331	330	7	dec	DATE
dti-1331	331	1	32(12):1337–50	CARDINAL
dti-1331	332	1	parsons	PERSON
dti-1331	332	2	c.g.	GPE
dti-1331	332	3	w.	PERSON
dti-1331	332	4	1998	DATE
dti-1331	335	1	11:523–69	CARDINAL
dti-1331	335	2	pellegrini	PERSON
dti-1331	335	3	j.w.	GPE
dti-1331	335	4	lipton, s.a.	ORG
dti-1331	336	1	n-methyl-d-aspartate	QUANTITY
dti-1331	338	1	neurol.	GPE
dti-1331	339	1	33(4):403–7	CARDINAL
dti-1331	340	1	phillips	ORG
dti-1331	340	2	p.e.	GPE
dti-1331	340	3	g.d.	GPE
dti-1331	340	4	m.l.	GPE
dti-1331	340	5	wightman	PERSON
dti-1331	340	6	r.m.	GPE
dti-1331	340	7	2003	DATE
dti-1331	341	1	subsecond dopamine	ORG
dti-1331	342	1	422:614–8	CARDINAL
dti-1331	343	1	e.r.	GPE
dti-1331	343	2	s.g.	GPE
dti-1331	343	3	2004	DATE
dti-1331	346	1	25:1	CARDINAL
dti-1331	346	2	przedborski	PERSON
dti-1331	346	3	s.	PERSON
dti-1331	346	4	vila	GPE
dti-1331	346	5	m. 2003	PERSON
dti-1331	347	1	1-methyl-4	QUANTITY
dti-1331	348	1	ann	PERSON
dti-1331	348	2	n.y.	GPE
dti-1331	348	3	acad	ORG
dti-1331	349	1	sci.	ORG
dti-1331	349	2	991:189–98	CARDINAL
dti-1331	350	1	rabey	GPE
dti-1331	350	2	j.m.	GPE
dti-1331	352	1	rao	PERSON
dti-1331	353	1	dogan, a.	ORG
dti-1331	353	2	todd	PERSON
dti-1331	353	3	k.g. et al.	GPE
dti-1331	353	4	2001	DATE
dti-1331	353	5	aug 17	DATE
dti-1331	353	6	nmda	ORG
dti-1331	355	1	911(1):96–100	DATE
dti-1331	355	2	b.	PERSON
dti-1331	355	3	mobius	PERSON
dti-1331	355	4	h.j.	GPE
dti-1331	355	5	a. et al	PERSON
dti-1331	355	6	2000	DATE
dti-1331	355	7	july 20–25	DATE
dti-1331	356	1	nmda	ORG
dti-1331	356	2	24-week	DATE
dti-1331	358	1	8th	ORDINAL
dti-1331	358	2	stockholm	GPE
dti-1331	359	1	b.	PERSON
dti-1331	359	2	r.	NORP
dti-1331	359	3	stamer	GPE
dti-1331	359	4	a. et al	PERSON
dti-1331	359	5	2003	DATE
dti-1331	360	1	nmda	ORG
dti-1331	362	1	j. med.	PERSON
dti-1331	363	1	348:1333–41	CARDINAL
dti-1331	364	1	rothman	ORG
dti-1331	364	2	s.m.	GPE
dti-1331	364	3	olney	GPE
dti-1331	364	4	j.w. 1987	GPE
dti-1331	366	1	neurosci	PERSON
dti-1331	366	2	10:299–302	CARDINAL
dti-1331	366	3	salthun-lassalle	PERSON
dti-1331	366	4	hirsch	PERSON
dti-1331	366	5	e.c.	GPE
dti-1331	366	6	wolfart	PERSON
dti-1331	366	7	j.	PERSON
dti-1331	366	8	michel	PERSON
dti-1331	368	1	j. neurosi	PERSON
dti-1331	368	2	24:5922–30	CARDINAL
dti-1331	368	3	schmitt, f., van dyck	ORG
dti-1331	368	4	c.	GPE
dti-1331	368	5	olin	GPE
dti-1331	368	6	j.	PERSON
dti-1331	368	7	2006	DATE
dti-1331	373	1	20(4):255–62	CARDINAL
dti-1331	373	2	seeman	PERSON
dti-1331	373	3	caruso	PERSON
dti-1331	373	4	m. 2007,	PERSON
dti-1331	373	5	nov 13	DATE
dti-1331	374	1	62(2):149–53	CARDINAL
dti-1331	375	1	seif ej	PERSON
dti-1331	375	2	rossberg	GPE
dti-1331	375	3	c. et al	PERSON
dti-1331	375	4	1990	DATE
dti-1331	375	5	aug 21	DATE
dti-1331	378	1	j. pharmacol.	ORG
dti-1331	378	2	j. 85(1):19–24	PERSON
dti-1331	379	1	stieg	PERSON
dti-1331	379	2	p.e.	GPE
dti-1331	379	3	s.	PERSON
dti-1331	379	4	warach	GPE
dti-1331	379	5	s. et al	PERSON
dti-1331	379	6	1999	DATE
dti-1331	379	7	jun 30	DATE
dti-1331	380	1	j. pharmacol.	ORG
dti-1331	380	2	375(1–3):115–20	CARDINAL
dti-1331	380	3	85	CARDINAL
dti-1331	380	4	2008:3	CARDINAL
dti-1331	380	5	k. 2004	PERSON
dti-1331	382	1	india	GPE
dti-1331	382	2	52(3):307–9	CARDINAL
dti-1331	383	1	m.	PERSON
dti-1331	383	2	grossberg	PERSON
dti-1331	383	3	g. et al	PERSON
dti-1331	383	4	2003	DATE
dti-1331	384	1	american	NORP
dti-1331	384	2	annual	DATE
dti-1331	384	3	san francisco	GPE
dti-1331	384	4	p.n.	GPE
dti-1331	384	5	m.r.	GPE
dti-1331	384	6	grossberg	PERSON
dti-1331	384	7	g.t.	GPE
dti-1331	384	8	graham	PERSON
dti-1331	384	9	s.m.	GPE
dti-1331	384	10	mcdonald, s.	ORG
dti-1331	384	11	gergel	ORG
dti-1331	384	12	i. 2004	PERSON
dti-1331	386	1	291:317–24	CARDINAL
dti-1331	387	1	weller	ORG
dti-1331	387	2	m.	PERSON
dti-1331	387	3	finiels-marlier	TIME
dti-1331	387	4	f.	PERSON
dti-1331	387	5	s.m.	GPE
dti-1331	387	6	1993	DATE
dti-1331	388	1	nmda	ORG
dti-1331	391	1	wenk	PERSON
dti-1331	391	2	g.l.	GPE
dti-1331	391	3	zajaczkowski	PERSON
dti-1331	391	4	w.	PERSON
dti-1331	391	5	1997	DATE
dti-1331	391	6	feb	DATE
dti-1331	391	7	b. behav	PERSON
dti-1331	392	1	83	DATE
dti-1331	392	2	1–2):129–33	CARDINAL
dti-1331	393	1	wilcock	PERSON
dti-1331	393	2	g.	PERSON
dti-1331	393	3	mobius	PERSON
dti-1331	393	4	stoffler, a. 2002	ORG
dti-1331	394	1	500	CARDINAL
dti-1331	395	1	17:297–305	PRODUCT
dti-1331	396	1	winblad	PERSON
dti-1331	396	2	b.	PERSON
dti-1331	396	3	mobius	PERSON
dti-1331	396	4	a. 2002	DATE
dti-1331	398	1	j. neural	ORG
dti-1331	399	1	transm	ORG
dti-1331	399	2	winblad	PERSON
dti-1331	399	3	b.	PERSON
dti-1331	399	4	jones	GPE
dti-1331	399	5	r.w.	GPE
dti-1331	399	6	2006	DATE
dti-1331	399	7	september	DATE
dti-1331	402	1	wu	PERSON
dti-1331	402	2	j.q.	GPE
dti-1331	402	3	anwyl	GPE
dti-1331	402	4	r.	NORP
dti-1331	402	5	rowan	PERSON
dti-1331	402	6	m.j. 1995	PERSON
dti-1331	403	1	nmda	ORG
dti-1331	404	1	neuroreport	GPE
dti-1331	404	2	6:2409–13	CARDINAL
dti-1331	406	1	20%	PERCENT
dti-1331	407	1	srgb	CARDINAL
dti-1331	408	1	u.s.	GPE
dti-1331	408	2	srgb	CARDINAL
dti-1331	410	1	1.4	CARDINAL
dti-1331	411	1	100	CARDINAL
dti-1331	411	2	/opm 1	LAW
dti-1331	411	3	1	CARDINAL
dti-1331	413	1	/downsamplecolorimages	NORP
dti-1331	413	2	300	CARDINAL
dti-1331	414	1	1.50000	CARDINAL
dti-1331	415	1	0.15	CARDINAL
dti-1331	416	1	1 1 1 1] /vsamples	QUANTITY
dti-1331	418	1	0.15	CARDINAL
dti-1331	419	1	1 1 1 1] /vsamples	QUANTITY
dti-1331	421	1	256	CARDINAL
dti-1331	421	2	256	CARDINAL
dti-1331	421	3	30	CARDINAL
dti-1331	421	4	256	CARDINAL
dti-1331	421	5	256	CARDINAL
dti-1331	422	1	300	CARDINAL
dti-1331	423	1	1.50000	CARDINAL
dti-1331	425	1	0.15	CARDINAL
dti-1331	426	1	1 1 1 1] /vsamples	QUANTITY
dti-1331	428	1	0.15	CARDINAL
dti-1331	429	1	1 1 1 1] /vsamples	QUANTITY
dti-1331	431	1	256	CARDINAL
dti-1331	431	2	256	CARDINAL
dti-1331	431	3	30	CARDINAL
dti-1331	431	4	256	CARDINAL
dti-1331	431	5	256	CARDINAL
dti-1331	431	6	30	CARDINAL
dti-1331	431	7	1200	CARDINAL
dti-1331	431	8	-1	ORG
dti-1331	431	9	1.50000	CARDINAL
dti-1331	433	1	0.00000 0.00000 0.00000 0.00000	MONEY
dti-1331	434	1	0.00000 0.00000 0.00000 0.00000	MONEY
dti-1331	443	1	/suo	ORG
dti-1331	448	1	2400 2400	CARDINAL